Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Esa Medika Mandiri Tbk. (EMMI) vs Champion Pacific Indonesia Tbk. (IGAR)

Esa Medika Mandiri Tbk.Trading
Champion Pacific Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Esa Medika Mandiri Tbk. dan Champion Pacific Indonesia Tbk.: Esa Medika Mandiri Tbk. diperdagangkan di Rp344 (kapitalisasi pasar 620,46 M, volume 24 jam 3,2 jt), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp446 (kapitalisasi pasar 411,93 M, volume 24 jam 26,4 rb). Perbedaan utamanya: Esa Medika Mandiri Tbk. lebih besar dari sisi kapitalisasi pasar, dan Esa Medika Mandiri Tbk. lebih aktif diperdagangkan (3,2 jt vs 26,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

EMMIIGAR
Kapitalisasi Pasar
620,46 M411,93 M
Volume
3,2 jt26,4 rb
Lot
31,95 rb264
Perputaran
1,11 M11,6 jt
Harga Rata-rata
347,32439,21
Nilai Transaksi
1,11 M11,6 jt
Harga Ekuilibrium Indikatif
356
Volume Ekuilibrium Indikatif
50,8 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EMMI
Lihat detail
IGAR
Lihat detail

Tentang Esa Medika Mandiri Tbk.

PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.

Selengkapnya di halaman EMMI

Tentang Champion Pacific Indonesia Tbk.

PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.

Selengkapnya di halaman IGAR